Investigation of prognostic markers in endemic Burkitt lymphoma

Peixun Zhou; Alexander Newman; Susan Van Noorden; Kondwani Banda; George Chagaluka; Irvin  Lampert; Amy Erhorn; Chris Bacon; Simon  Bailey; Elizabeth  Molyneux; Vikki Rand

Investigation of prognostic markers in endemic Burkitt lymphoma

Peixun Zhou, Alexander Newman, Susan Van Noorden, Kondwani Banda, George Chagaluka, Irvin Lampert, Amy Erhorn, Chris Bacon, Simon Bailey, Elizabeth Molyneux, Vikki Rand

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

Unlike many other childhood cancers, genomic abnor-
malities are not used in the clinical management of paediatric Bur-
kitt lymphoma (BL) and few prognostic biomarkers have been
identiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13q
are the only abnormalities that have been associated with an adverse
prognosis in the context of a clinical trial. Gains of 13q have also
been reported, including gain of the miR17HG locus, but the prog-
nostic value in endemic BL is unknown

Original language	English
Pages (from-to)	2-2
Journal	British Journal of Haematology
Volume	171
Issue number	Suppl 1
Publication status	Published - 4 Oct 2015
Event	Fifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma - Varase, Italy Duration: 22 Oct 2015 → 24 Oct 2015 https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13753

Access to Document

https://onlinelibrary.wiley.com/doi/10.1111/bjh.13753

Cite this

@article{babb8a51baa8438ab196af7c17f11416,

title = "Investigation of prognostic markers in endemic Burkitt lymphoma",

abstract = "Unlike many other childhood cancers, genomic abnor-malities are not used in the clinical management of paediatric Bur-kitt lymphoma (BL) and few prognostic biomarkers have beenidentiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13qare the only abnormalities that have been associated with an adverseprognosis in the context of a clinical trial. Gains of 13q have alsobeen reported, including gain of the miR17HG locus, but the prog-nostic value in endemic BL is unknown",

author = "Peixun Zhou and Alexander Newman and {Van Noorden}, Susan and Kondwani Banda and George Chagaluka and Irvin Lampert and Amy Erhorn and Chris Bacon and Simon Bailey and Elizabeth Molyneux and Vikki Rand",

year = "2015",

month = oct,

day = "4",

language = "English",

volume = "171",

pages = "2--2",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "Suppl 1",

note = "Fifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma ; Conference date: 22-10-2015 Through 24-10-2015",

url = "https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13753",

}

TY - JOUR

T1 - Investigation of prognostic markers in endemic Burkitt lymphoma

AU - Zhou, Peixun

AU - Newman, Alexander

AU - Van Noorden, Susan

AU - Banda, Kondwani

AU - Chagaluka, George

AU - Lampert, Irvin

AU - Erhorn, Amy

AU - Bacon, Chris

AU - Bailey, Simon

AU - Molyneux, Elizabeth

AU - Rand, Vikki

PY - 2015/10/4

Y1 - 2015/10/4

N2 - Unlike many other childhood cancers, genomic abnor-malities are not used in the clinical management of paediatric Bur-kitt lymphoma (BL) and few prognostic biomarkers have beenidentiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13qare the only abnormalities that have been associated with an adverseprognosis in the context of a clinical trial. Gains of 13q have alsobeen reported, including gain of the miR17HG locus, but the prog-nostic value in endemic BL is unknown

AB - Unlike many other childhood cancers, genomic abnor-malities are not used in the clinical management of paediatric Bur-kitt lymphoma (BL) and few prognostic biomarkers have beenidentiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13qare the only abnormalities that have been associated with an adverseprognosis in the context of a clinical trial. Gains of 13q have alsobeen reported, including gain of the miR17HG locus, but the prog-nostic value in endemic BL is unknown

M3 - Meeting Abstract

SN - 0007-1048

VL - 171

SP - 2

EP - 2

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - Suppl 1

T2 - Fifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma

Y2 - 22 October 2015 through 24 October 2015

ER -

Investigation of prognostic markers in endemic Burkitt lymphoma

Abstract

Access to Document

Fingerprint

Cite this